We employed RPPA to map the basal activation state and adaptive responses to BRAF inhibition on a broader range of signaling pathway proteins in our panel of 12 BRAFV600E melanomas as well as 4 BRAFwt melanomas (Figure 5 and Supplementary Figures 2, 3 and 5). This evidence concerns the gene BRAF and melanoma.